Physician profile
Matthew Marriott
NPI 1538104393
$713.44
in general payments reported to CMS, 2019-2025
19 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $183 · 2024: $531.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $713.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $713.44 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $106.38 | 2023-2024 | Ozempic, Rybelsus |
| Lilly USA, LLC | $102.64 | 2023-2024 | Zepbound, Mounjaro, Jardiance |
| Astrazeneca Pharmaceuticals LP | $96.61 | 2024 | Farxiga, Fasenra, Breztri |
| Dexcom, INC. | $45.40 | 2024 | Dexcom G6 Transmitter |
| Pfizer INC. | $41.84 | 2024 | |
| Corcept Therapeutics | $33.93 | 2023-2024 | Korlym |
| Amgen INC. | $30.19 | 2024 | Repatha, Otezla |
| Glaxosmithkline, LLC. | $27.37 | 2024 | Trelegy Ellipta |
| Takeda Pharmaceuticals U.S.A., INC. | $26.73 | 2023 | Trintellix |
| Boehringer Ingelheim Pharmaceuticals, INC. | $25.42 | 2024 | Jardiance |
| Lundbeck LLC | $24.87 | 2024 | Rexulti |
| Almatica Pharma LLC | $24.14 | 2023 | Gralise |
| Abbott Laboratories | $21.73 | 2023 | Freestyle Libre 3 |
| Exact Sciences Corporation | $21.47 | 2023 | Cologuard Collection Kit |
| Astellas Pharma US INC | $21.42 | 2024 | Veozah |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $18.55 | 2024 | |
| Esperion Therapeutics, INC. | $16.76 | 2024 | Nexletol |
| Phathom Pharmaceuticals, INC. | $14.92 | 2024 | Voquezna |
| Xeris Pharmaceuticals, INC. | $13.07 | 2024 | Gvoke Hypopen |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Matthew Marriott listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.